Competing in a crowded infectious disease market, a client needed to maximize digital media efficiency. IQVIA analyzed programmatic partners, identifying optimal platforms for lower-funnel conversions. Media dollars were reinvested into high-performing channels, boosting qualified audience reach by 19.6%. The campaign generated $1.75M in incremental new-to-brand prescription revenue over six months without increasing costs. The case demonstrates how IQVIA’s programmatic expertise drives ROI by aligning media spend with effective targeting strategies, ensuring sustained competitive advantage in pharma marketing.

Join for free to read